IDYAIDEAYA Biosciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 16916
Ticker: IDYA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2019-05-23
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: IDYA

Detail

Enriched 2026-08-14 20:47

Market cap: $3,558,316,681.92
Shares outstanding (class): 87,860,920
Shares outstanding (weighted): 96,274,802
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 145
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.ideayabio.com
Description: IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Market cap and share counts drift.

Funds holding this security

119 funds · 122 positions · $660.56M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
SMALLCAP World Fund Inc SMALLCAP World Fund Inc	—	$156.09M	0.19%	4,684,432 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$88.90M	0.00%	2,667,924 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$68.70M	0.10%	2,061,960 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$54.27M	0.73%	1,628,726 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$32.58M	0.04%	977,683 NS	FIGI
Janus Henderson Triton Fund JANUS INVESTMENT FUND	—	$28.18M	0.54%	845,786 NS	FIGI
Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND	—	$24.62M	0.47%	738,748 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$24.17M	0.19%	725,397 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$20.51M	0.25%	615,636 NS	FIGI
Janus Henderson Venture Fund JANUS INVESTMENT FUND	—	$17.30M	0.56%	519,128 NS	FIGI
Global Small Capitalization Fund AMERICAN FUNDS INSURANCE SERIES	—	$15.96M	0.56%	479,111 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$14.78M	0.12%	443,518 NS	FIGI
abrdn Healthcare Investors —	—	$11.16M	0.98%	335,020 NS	FIGI
N/A —	—	$9.34M	0.59%	280,261 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$8.63M	0.08%	259,143 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERIDYA
FIGI_COMPOSITEBBG00CTZ4D83
FIGI_SHARE_CLASSBBG00CTZ4D92
CIK0001676725
ISINUS45166A1025
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: IDEAYA Biosciences is a clinical-stage biotech company, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.